Urolution Medical, Inc.

A Minnesota-based medical device company advancing urological care through purposeful design.

The Foley catheter became routine. Its drawbacks shouldn’t have to be.

Urolution Medical develops differentiated technologies for a familiar part of urological care. The Foley catheter has been in use for nearly a century, yet catheter-related discomfort and complications remain important challenges.

OpenFlo® is our first technology. By reconsidering how a catheter drains and interacts with the bladder, we set out to improve the experience of a device that so many patients rely on.

Explore OpenFlo®

Est. 2022

Since 2022, Urolution has patented the OpenFlo® technology and design, manufactured the device, and completed testing to support its FDA 510(k) submission. OpenFlo® received FDA 510(k) clearance in October 2026.

Looking Forward

Urolution is preparing clinical studies to evaluate comparative catheter performance and patient outcomes, while advancing manufacturing and commercialization.

As OpenFlo® moves toward broader market introduction, we’re pursuing strategic partnerships, additional capital, and commercial relationships with established healthcare organizations.

Connect with Urolution